Manipulation of Qa‐1‐restricted CD8 Suppressor Cell Activity in Experimental Autoimmune Encephalomyelitis

Linrong Lu,Hye-Jung Kim,Miriam Werneck,Harvey Cantor
DOI: https://doi.org/10.1096/fasebj.22.2_supplement.393
2008-01-01
Abstract:Peripheral regulation of CD4 T cell responses by other cell types is essential for the maintenance of self-tolerance and prevention of autoimmune disease. Our previous studies have revealed a role for Qa-1-restricted CD8 suppressor cell activity in controlling EAE development. Here we have extended our understanding of this process by creating two Qa-1 mutant knock-in mouse strains according to its ability to bind the two different receptors: the T-cell receptor (TCR) and the CD94/NKG2A receptors. The Qa-1 D227K mutant carries a point mutation at its CD8 binding region which prevents Qa1/CD8 interaction, where as Qa1 R72A mutant cannot bind CD94/NKG2A receptors. Studies from Qa1 D227K mice provided direct molecular evidence that Qa-1 mediated suppression is linked to its ability to stimulate CD8+ T cells through TCR engagement, which is dependent on the binding to the CD8 co-receptor. More importantly, by using Qa1 R72A mutant CD4 T cells, we found out that CD8 suppressive activity is inhibited by the Qa-1-CD94/NKG2A interaction between target CD4 T cells and CD8 suppressor cells. Disruption of this interaction by the R72A Qa1 mutant leads to enhanced CD8 suppressive activity, which in turn, diminishes the development of EAE induced by pathogenic CD4 T cells. Finally, we showed that blockade of the Qa1-NKG2A interaction by antibody can mimic the effect of the R72A genetic mutant and can be used to treat EAE.
What problem does this paper attempt to address?